Tetsuhiro Kasamatsu

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Venues

International journal of molecular sciences

Clinical and experimental medicine

Cancers

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tetsuhiro Kasamatsu
Implications of Senescent T Cells for Cancer Immunotherapy. Cancers 15 (24) (2023)
Tsukasa Oda, Nanami Gotoh, Tetsuhiro Kasamatsu, Hiroshi Handa, Takayuki Saitoh, Nobuo Sasaki
DNA damage-induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation. Cell proliferation (2023)
Rei Ishihara, Tsukasa Oda, Yuki Murakami, Ikuko Matsumura, Saki Watanabe, Yuta Asao, Yuta Masuda, Nanami Gotoh, Tetsuhiro Kasamatsu, Hisashi Takei, Nobuhiko Kobayashi, Nobuo Sasaki, Takayuki Saitoh, Hirokazu Murakami, Hiroshi Handa
Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression. International journal of molecular sciences 24 (3) (2023)
Rei Ishihara, Tsukasa Oda, Yuki Murakami, Ikuko Matsumura, Saki Watanabe, Yuta Asao, Yuta Masuda, Nanami Gotoh, Tetsuhiro Kasamatsu, Hisashi Takei, Nobuhiko Kobayashi, Nobuo Sasaki, Takayuki Saitoh, Hirokazu Murakami, Hiroshi Handa
Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression. International journal of molecular sciences 24 (3) (2023)
Tetsuhiro Kasamatsu
Implications of Senescent T Cells for Cancer Immunotherapy. Cancers 15 (24) (2023)
Tetsuhiro Kasamatsu, Maaya Awata-Shiraiwa, Rei Ishihara, Yuki Murakami, Yuta Masuda, Nanami Gotoh, Tsukasa Oda, Akihiko Yokohama, Ikuko Matsumura, Hiroshi Handa, Norifumi Tsukamoto, Hirokazu Murakami, Takayuki Saitoh
Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression. Clinical and experimental medicine (2023)
Rei Ishihara, Tsukasa Oda, Yuki Murakami, Ikuko Matsumura, Saki Watanabe, Yuta Asao, Yuta Masuda, Nanami Gotoh, Tetsuhiro Kasamatsu, Hisashi Takei, Nobuhiko Kobayashi, Nobuo Sasaki, Takayuki Saitoh, Hirokazu Murakami, Hiroshi Handa
Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression. International journal of molecular sciences 24 (3) (2023)
Tetsuhiro Kasamatsu, Nao Hashimoto, Nao Sakaya, Maaya Awata-Shiraiwa, Rei Ishihara, Yuki Murakami, Yuta Masuda, Nanami Gotoh, Kazue Nagai, Tsukasa Oda, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Norifumi Tsukamoto, Kunihiko Hayashi, Hirokazu Murakami
IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma. Clinical and experimental medicine 21 (2) (2021)
Tsukasa Oda, Ruri Nakamura, Tetsuhiro Kasamatsu, Nanami Gotoh, Keiko Okuda, Takayuki Saitoh, Hiroshi Handa, Hirokazu Murakami, Takayuki Yamashita
DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway. Cancer gene therapy (2021)
Hiroshi Handa, Kazuki Honma, Tsukasa Oda, Nobuhiko Kobayashi, Yuko Kuroda, Kei Kimura-Masuda, Saki Watanabe, Rei Ishihara, Yuki Murakami, Yuta Masuda, Ken-Ichi Tahara, Hisashi Takei, Tetsuhiro Kasamatsu, Takayuki Saitoh, Hirokazu Murakami
Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression. International journal of molecular sciences 21 (19) (2020)
Nanami Gotoh, Yusuke Minato, Takayuki Saitoh, Noriyuki Takahashi, Tetsuhiro Kasamatsu, Kana Souma, Tsukasa Oda, Takumi Hoshino, Toru Sakura, Takuma Ishizaki, Hiroaki Shimizu, Makiko Takizawa, Akihiko Yokohama, Norifumi Tsukamoto, Hiroshi Handa, Hirokazu Murakami
PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes. European journal of haematology 104 (6) (2020)
Tetsuhiro Kasamatsu, Maaya Awata, Rei Ishihara, Yuki Murakami, Nanami Gotoh, Morio Matsumoto, Morio Sawamura, Akihiko Yokohama, Hiroshi Handa, Norifumi Tsukamoto, Takayuki Saitoh, Hirokazu Murakami
PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma. Clinical and experimental medicine 20 (1) (2019)
Tetsuhiro Kasamatsu, Rumi Ino, Noriyuki Takahashi, Nanami Gotoh, Yusuke Minato, Makiko Takizawa, Akihiko Yokohama, Hiroshi Handa, Takayuki Saitoh, Norifumi Tsukamoto, Hirokazu Murakami
PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia. British journal of haematology 180 (5) (2018)
Tetsuhiro Kasamatsu, Shuji Ozaki, Takayuki Saitoh, Jun Konishi, Kazutaka Sunami, Mitsuhiro Itagaki, Hideki Asaoku, Takaaki Cho, Hiroshi Handa, Shotaro Hagiwara, Toshio Wakayama, Akiko Negoro, Naoki Takezako, Naoko Harada, Yoshiaki Kuroda, Chiaki Nakaseko, Takaaki Miyake, Nobumasa Inoue, Hiroyuki Hata, Chihiro Shimazaki, Tatsuharu Ohno, Junya Kuroda, Tohru Murayama, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, Eiich Nagura, Kazuyuki Shimizu
Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma. Hematological oncology 36 (5) (2018)
Tetsuhiro Kasamatsu, Mari Kimoto, Noriyuki Takahashi, Yusuke Minato, Nanami Gotoh, Makiko Takizawa, Morio Matsumoto, Morio Sawamura, Akihiko Yokohama, Hiroshi Handa, Norifumi Tsukamoto, Takayuki Saitoh, Hirokazu Murakami
IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma. Hematological oncology 36 (1) (2017)

Tetsuhiro Kasamatsu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tetsuhiro Kasamatsu